FOXP1inhibits cell growth and attenuates tumorigenicity of neuroblastoma
Authors:
- Sandra AckermannSASandra Ackermann
- Hayriye KocakHKHayriye Kocak
- Barbara HeroBHBarbara Hero
- Volker EhemannVEVolker Ehemann
- Yvonne KahlertYKYvonne Kahlert
- André OberthuerAOAndré Oberthuer
- Frederik RoelsFRFrederik Roels
- Jessica TheißenJTJessica Theißen
- Margarete OdenthalMOMargarete Odenthal
- Frank BertholdFBFrank Berthold
- Matthias FischerMFMatthias Fischer
Open Access
- 18 November 2014
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 840
Abstract
Segmental genomic copy number alterations, such as loss of 11q or 3p and gain of 17q, are well established markers of poor outcome in neuroblastoma, and have been suggested to comprise tumor suppressor genes or oncogenes, respectively. The gene forkhead box P1 (FOXP1) maps to chromosome 3p14.1, a tumor suppressor locus deleted in many human cancers including neuroblastoma. FoxP1 belongs to a family of winged-helix transcription factors that are involved in processes of cellular proliferation, differentiation and neoplastic transformation. Microarray expression profiles of 476 neuroblastoma specimens were generated and genes differentially expressed between favorable and unfavorable neuroblastoma were identified. FOXP1 expression was correlated to clinical markers and patient outcome. To determine whether hypermethylation is involved in silencing of FOXP1, methylation analysis of the 5′ region of FOXP1 in 47 neuroblastomas was performed. Furthermore, FOXP1 was re-expressed in three neuroblastoma cell lines to study the effect of FOXP1 on growth characteristics of neuroblastoma cells. Low expression of FOXP1 is associated with markers of unfavorable prognosis like stage 4, age >18 months and MYCN amplification and unfavorable gene expression-based classification (P < 0.001 each). Moreover, FOXP1 expression predicts patient outcome accurately and independently from well-established prognostic markers. Array-based CGH analysis of 159 neuroblastomas revealed that heterozygous loss of the FOXP1 locus was a rare event (n = 4), but if present, was associated with low FOXP1 expression. By contrast, DNA methylation analysis in 47 neuroblastomas indicated that hypermethylation is not regularly involved in FOXP1 gene silencing. Re-expression of FoxP1 significantly impaired cell proliferation, viability and colony formation in soft agar. Furthermore, induction of FOXP1 expression led to cell cycle arrest and apoptotic cell death of neuroblastoma cells. Our results suggest that down-regulation of FOXP1 expression is a common event in high-risk neuroblastoma pathogenesis and may contribute to tumor progression and unfavorable patient outcome.Keywords
This publication has 67 references indexed in Scilit:
- Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastomaCell Death & Disease, 2013
- NeuroblastomaSeminars in Pediatric Surgery, 2012
- An Alternative Splicing Switch Regulates Embryonic Stem Cell Pluripotency and ReprogrammingCell, 2011
- Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patientsThe Pharmacogenomics Journal, 2010
- MicroRNA-34a Perturbs B Lymphocyte Development by Repressing the Forkhead Box Transcription Factor Foxp1Immunity, 2010
- Repression of BIRC5/Survivin by FOXO3/FKHRL1 Sensitizes Human Neuroblastoma Cells to DNA Damage-induced ApoptosisMolecular Biology of the Cell, 2009
- The evolution of Fox genes and their role in development and diseaseNature Reviews Genetics, 2009
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysProceedings of the National Academy of Sciences, 2008
- RETRACTED: Methylation Mediated Silencing of MicroRNA-1 Gene and Its Role in Hepatocellular CarcinogenesisCancer Research, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005